FSI invests EUR 20 Million in Cerenis Therapeutics

Posted on 07/28/2010


According to the press release, “Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the “good” cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this […]

Get News, People, and Transactions, Delivered to Your Inbox